Panacea Biotech-A high risk, huge reward stock!
Panacea biotech is in news for developing Dengue vaccine.
Technically, stock has bounced from support trendline and is looking strong to test ATH levels once again which can be around 2x from CMP.
Keep in watchlist. A very risky volatile stock and is not a recommendation.
Technically, stock has bounced from support trendline and is looking strong to test ATH levels once again which can be around 2x from CMP.
Keep in watchlist. A very risky volatile stock and is not a recommendation.
Commento
300+ done from 240. T1 will be hit very soon!
Declinazione di responsabilità
Le informazioni ed i contenuti pubblicati non costituiscono in alcun modo una sollecitazione ad investire o ad operare nei mercati finanziari. Non sono inoltre fornite o supportate da TradingView. Maggiori dettagli nelle Condizioni d'uso.